Citigroup
ROCM

Citigroup’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

Citigroup’s Portfolio ROCM Stock Details ROCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,414
Closed -$28K – 7395
2013
Q3 		$28K Buy
1,414
+212
+18% +$3.46K ﹤0.01% 5719
2013
Q2 		$17K Buy
+1,202
New +$17.2K ﹤0.01% 5912

Citigroup's ROCM Position: Q4 2013 in Review

Citigroup sold out of ROCHESTER MEDICAL CORP (ROCM) in Q4 2013, closing a stake of 1,414 shares — an estimated $28K sold.

Citigroup first reported a position in ROCM in Q2 2013 and held it in 2 quarters. The position peaked at $28K in Q3 2013. 0 funds tracked by Wall St. Rank hold ROCM as of Q4 2013.

  • Citigroup reported no remaining ROCHESTER MEDICAL CORP position as of Q4 2013 after selling out during the quarter.
  • Citigroup sold 1,414 ROCHESTER MEDICAL CORP shares in Q4 2013, an estimated $28K.
  • Citigroup first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 2 quarters.
  • Citigroup's ROCHESTER MEDICAL CORP position peaked at $28K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q4 2013.

Based on Citigroup's 13F filing for Q4 2013, filed 14 Feb 2014.